APA (7th ed.) Citation

Monteiro, P., Aguiar, C., Matos, P., Silva-Nunes, J., Birne, R., Branco, P., . . . Polónia, J. (2019). Effect of empagliflozin beyond glycemic control: Cardiovascular benefit in patients with type 2 diabetes and established cardiovascular disease. Elsevier.

Chicago Style (17th ed.) Citation

Monteiro, Pedro, Carlos Aguiar, Pedro Matos, José Silva-Nunes, Rita Birne, Patrícia Branco, Joaquim Calado, Miguel Melo, and Jorge Polónia. Effect of Empagliflozin Beyond Glycemic Control: Cardiovascular Benefit in Patients with Type 2 Diabetes and Established Cardiovascular Disease. Elsevier, 2019.

MLA (8th ed.) Citation

Monteiro, Pedro, et al. Effect of Empagliflozin Beyond Glycemic Control: Cardiovascular Benefit in Patients with Type 2 Diabetes and Established Cardiovascular Disease. Elsevier, 2019.